All Updates

All Updates

icon
Filter
Funding
Sweden-based Mentice receives a SEK 3 million grant
Extended Reality
Nov 9, 2022
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Microsoft launches Face Check with Microsoft Entra Verified ID
Facial Recognition
Sep 11, 2024
Funding
3DEO raises USD 3.5 million in strategic investment from Mizuho Bank
Additive Manufacturing
Yesterday
Product updates
HyperWrite launches open-source AI model Reflection 70 billion
Generative AI Applications
Sep 5, 2024
Product updates
Google begins US rollout of AI-powered Ask Photos feature
Generative AI Applications
Sep 5, 2024
Funding
Management news
HDAX Therapeutics raises USD 3.2 million in seed funding to progress pipeline and advance preclinical candidates into trials
Precision Medicine
Sep 5, 2024
Partnerships
Sequentify partners with Dexter to expand genomic diagnostics in Romania
Precision Medicine
Sep 5, 2024
Partnerships
Elevate partners with Cultivatd for European expansion
Vertical Farming
Sep 5, 2024
Product updates
Moolec confirms harvest of its genetically engineered plant-grown products
Crop Biotech
Sep 5, 2024
Extended Reality

Extended Reality

Nov 9, 2022

Sweden-based Mentice receives a SEK 3 million grant

Funding

  • Mentice, a simulation software provider for healthcare, received a SEK 3 million (~USD 280,000) grant from Vinnova, the Swedish government agency for innovation. Through this Mentice will also be a part of the TASTI project, a joint European research project financed by Vinnova. 

  • The proceeds will be used to improve the synthetic image generation and realism in its virtual reality software. 

  • Mentice develops medical devices and VR-based simulation software for healthcare professionals. The company’s solutions cover neurovascular, cardiovascular, and peripheral interventions and it claims to be the pioneer in endovascular therapies. Mentice also holds around 50 medical simulation patents across 30 different training procedures. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.